Effect of poloxamer 188 on in vitro dissolution properties of antipsychotic solid dispersions

International Journal of Pharmaceutical Sciences Review and Research

Volumn 10, Issue 1, 2011, Pages 15-19

  Prasanthi, N L ^a   Manikiran, S S ^a   Sowmya, S ^a   Anusha, B ^a   Rama Rao, N ^a  

^a CHALAPATHI INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Dissolution rate; Mean dissolution time; Poloxamer 188; Solubility; Ziprasidone

Indexed keywords

DRUG CARRIER; POLOXAMER; ZIPRASIDONE;

ARTICLE; BULK DENSITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISPERSION; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; EXCIPIENT COMPATIBILITY; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MELTING POINT; SOLID STATE;

EID: 84856519365     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Amidon, G. L., Lennernasw, H., Shah, V. P., Crison JR. Theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. REs. 1995, 12, 413-420
2. Leuner, C., Dressman, J., Improving rug solubility for oral delivery using solid dispersions. Eur. J.Pharm. Biopharm. 2000, 50, 47-60
3. US FDA. Guidelines for industry, Waiver of in vivo bioavailability and bioequivalence studies for immediate release solid oral dosage forms based on a biopharmaceutics classification system., Center for Drug Evaluation and Research, Fishers Lane, Rockville, MD August 2000; 1-13
4. Lobenberg, R., Amidon, G.L., Modern Bioavailability, Bioequivalence and Biopharmaceutics Classification System; New Scientific Approaches to International Regulatory Standards Eur. J. Pharm. Biopharm. 2000, 50, 3-12
5. Sekiguchi K, Obi N. Studies on absorption of eutectic mixture I. A comparison of the behaviour of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull. 9; 1961: 866-872
6. Martindale. The Extra Pharmacopoeia. 31st Ed. London: Pharmaceutical press, 2002
7. Goodman and Gilman. The pharmacological basis of therapeutics. 10th Ed., McGraw-Hill, 2001
8. Deshmukh SS, Potnis VV and Kute AB. Developmetn of dissoluiton medium from ziprasidone hydrochloride. Indian Pharmacist. 2006; V (47): 79-80
9. SC Shin; CW Cho, physico chemical characterization of piroxicam-poloxamer solid dispersions. Pharm. Dev. Tech., 1997, 2, 403-407
10. SR Vippagunta; KA Maul; S Tallavajhala; DJW Grant. Enhancing the dissolution rate of poorly water soluble drug nifedipine. Int. J. Pharm., 2002, 236, 111-123
11. A Wade; PJ Weller; Handbook of Pharmaceutical Excipients, American Pharmaceutical Association, Washington, DC, 1994, 907
12. Higuchi T, Connors K. Phase solubility techniques. Adv Ana Chem and Instrument. 1965; 4: 17-23
13. VR Sinha; MK Agarwal; R Kumria. Influence of Formulation and Excipient Variables on the Pellet Properties Prepared by Extrusion Spheronization. Current Drug Delivery, 2005, 2, 1-8
14. M Jaimini; AC Rana; YS Tanwar; Formulation and Evaluation of Famotidine Floating Tablets. Current Drug Delivery, 2007, 4, 51-55
15. Barzegar-Jalali M, Maleki N, Garjan A, et al. Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique. Drug Devl Ind Pharm. 2002; 28(6): 681-686.